The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Should be buying at these levels. Have to assume they're free to do so now results are out. If this is the last speed bump before we get back to near 2019 levels I'd expect an RNS or 2.
How they view the current price will tell us a lot. If its cheap etc...
I maintain it was a major over reaction. The fact the market was offloading like hell the day befor and it was a Friday as well so traders flocking for the door. Good results weren't priced in imo. so I hope we start to walk our way back up.
IAG is heading in the right direction and the developed world can't afford anymore restrictions.
Just more patience required. And hope oil helps us out.
Results weren't fantastic but this is an over reaction imo. Probably impacted by overall market sentiment. Nothing much changed today so I don't see a prolonged downward spiral unless it's market-wide. Hoping for a rebound into the afternoon.
If you've been following IAG you'd know the shoeters are right about 99% of the time. It indicates the SP direction almost to a T. Praying its the case this time... pretty sure we were expecting a profit this quarter so hopefully a surprise earnings
I think its very likely short term Sun, the market will give up 3% quite easily in the space of an hour lol. We've all seen it too many times. I'm hearing EU are looking to west African nations to increase output so hopefully there's some surprises but I suspect at keadt some volatility going into Friday. Definitely don't see a steady rise. I Considered selling when we went up this morning and sh@t it again lol
I reckon oil some time soon breaks lower, the high prices lead to demand destruction and the panic over inflation might ease slightly. Africa and Opec meet supply and Russia has less leverage over the price.
We'll head higher on the back of lower oil and lower inflation figures...
Reckon it's coming, just don't know how soon.
Thanks for that Karen
https://www.google.com/search?q=south%20park%20yelp%20gif&tbm=isch&prmd=vin&hl=en-GB&sa=X&ved=0CBUQtI8BKABqFwoTCKibwPuSxPcCFQAAAAAdAAAAABAH&biw=360&bih=630#imgrc=TLhzVXVhhovNBM
Mastercard Inc (MA.N) on Thursday reported first-quarter profit above Wall Street expectations and said consumers were braving stubbornly high inflation and concerns around new coronavirus variants to spend on travel, sending its shares up 3%.
Pent-up demand from Americans who stayed homebound for a prolonged period helped cross-border travel surpass 2019 levels in March for the first time since the COVID-19 pandemic began.
Bob Jordan, Chief Executive Officer, stated, "While the impact from the Omicron variant in January and February disrupted our anticipated profit recovery in first quarter 2022, we returned to strong profitability in March 2022 on surging travel demand. First quarter 2022 operating revenues per available seat mile (RASM, or unit revenues) increased slightly compared with first quarter 2019, representing our first quarterly RASM increase relative to respective 2019 levels since the pandemic began. Our operational performance improved during February and March 2022 following acute staffing challenges experienced in January due to the Omicron variant. We have made great progress against our hiring plans for this year, increasing our headcount by approximately 3,300 in first quarter 2022, alone, net of attrition. We remain intensely focused on our hiring and training efforts as we work diligently to restore our network and position the Company for future growth. While we are experiencing inflationary pressure from higher jet fuel prices, our fuel hedge is providing significant protection against rising oil prices.
"Based on current plans and expected continued strong bookings, we continue to expect to be solidly profitable for the remaining three quarters of this year, and for full year 2022.